Sign in

CIK 0001472012 · Non-accelerated filer

Immunome Inc.

Sign in to watch
Ticker
IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770694340
Phone
610-321-3700
Business address
18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$334,224
in 1 filing, $334K under 10b5-1 plans

Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Higgins Jack −$334K Chief Scientific Officer sold 17% of stake

Reading 56 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-10 SWAIN SANDRA M Director Grant or award · Director Stock Option (right to buy) +18,864 18,864
2025-06-03 BIENAIME JEAN JACQUES Director Purchase +5,000 $9.38 $47K 36,415
2025-03-27 Higgins Jack Chief Scientific Officer Option exercise +5,200 $1.35 $7K 18,729
2025-03-27 Higgins Jack Chief Scientific Officer Option exercise · Employee Stock option (right to buy) −5,200 173,840
2025-03-26 SIEGALL CLAY B President and CEO Purchase +137,100 $7.29 $999K 806,736
2025-03-25 BIENAIME JEAN JACQUES Director Purchase +7,800 $7.78 $61K 31,415
2025-03-24 BIENAIME JEAN JACQUES Director Purchase +7,000 $8.21 $57K 23,615
2025-03-24 Tsai Philip Chief Technology Officer Purchase +12,300 $8.42 $104K 33,300
2025-01-31 SIEGALL CLAY B President and CEO Purchase +150,000 $7.75 $1.2M 669,636
2024-11-22 SIEGALL CLAY B President and CEO Purchase +33,943 $9.78 $332K 519,636
2024-11-21 SIEGALL CLAY B President and CEO Purchase +66,057 $9.54 $630K 485,693
2024-11-21 Lechleider Robert Chief Medical Officer Purchase +15,805 $9.48 $150K 15,805
2024-11-21 Tsai Philip Chief Technology Officer Purchase +21,000 $9.43 $198K 21,000
2024-09-19 Rosett Max Chief Financial Officer Option exercise +42,000 $1.05 $44K 61,856
2024-09-19 Rosett Max Chief Financial Officer Sale −14,380 $16.01 $230K 47,476
2024-09-19 Rosett Max Chief Financial Officer Option exercise · Stock option (right to buy) −42,000 91,848
2024-08-19 Higgins Jack Chief Scientific Officer Gift −2,471 13,529
2024-08-16 BIENAIME JEAN JACQUES Director Purchase +7,000 $13.94 $98K 16,615
2024-08-15 Higgins Jack Chief Scientific Officer Option exercise +19,524 $1.35 $26K 19,524
2024-08-15 Higgins Jack Chief Scientific Officer Sale −3,524 $13.93 $49K 16,000

Page 6 of 8 · 159 trades